Skip to main content

Affordability Check

How to afford Sofosbuvir and Velpatasvir

Generic name: Velpatasvir and Sofosbuvir

Pick how you're covered. We'll show you the cheapest legitimate way to get Sofosbuvir and Velpatasvir — your insurance copay, manufacturer savings, charity grants, or cash price. It takes 30 seconds and we never ask for your personal information.

How are you covered for prescriptions?

Pick the one that fits you. We'll show you the cheapest way to get this drug.

Pick an option above to see your specific path.

Different insurance means different laws and different savings. For example, Medicare patients cannot use manufacturer copay cards (federal law) — but the manufacturer almost always has a Patient Assistance Program that gives the drug free.

About Sofosbuvir and Velpatasvir and its cost

What is this medication? Sofosbuvir and velpatasvir is a combination prescription medication used to treat chronic hepatitis C virus infection in both adults and children. This medication consists of two direct-acting antivirals that work together to prevent the virus from multiplying within the body. It is known as a pangenotypic treatment because it is effective against all six major genotypes of the hepatitis C virus. The primary goal of using this medication is to clear the virus from the bloodstream, leading to what is medically defined as a cure when the virus remains undetectable for several months after treatment ends.

The medication is usually administered as a single oral tablet taken once daily for a duration of twelve weeks. It can be prescribed for patients regardless of whether they have developed cirrhosis, though those with advanced liver disease might take it in combination with another drug called ribavirin. Most people tolerate the treatment well, with common side effects being limited to mild symptoms like headache or fatigue. Completing the entire course of the medication is essential for achieving a successful outcome and preventing the virus from returning or developing resistance to the treatment.

Sofosbuvir and Velpatasvir is made by Gilead Sciences. Like most brand-name drugs, it's priced at a high list price — but patients rarely pay that list price. The options above are the real paths most people use to get it affordably.

Common questions

What's the cheapest way to afford Sofosbuvir and Velpatasvir?

It depends on your insurance. On Medicare, apply for the manufacturer's Patient Assistance Program (PAP) — it gives the drug free if you meet income requirements. With private insurance, the manufacturer copay card usually drops your copay to $0-$25. Uninsured patients should compare the PAP with Cost Plus Drugs cash price.

Can I use a copay card with Medicare for Sofosbuvir and Velpatasvir?

No — federal law (the Anti-Kickback Statute) prohibits manufacturer copay cards on Medicare, Medicaid, TriCare, and VA prescriptions. But Gilead Sciences has a separate Patient Assistance Program for Medicare beneficiaries. Check the options above.

Does my Medicare Part D plan cover Sofosbuvir and Velpatasvir?

Part D coverage varies by plan. We query the CMS Prescription Drug Plan file to show you what percentage of plans cover it and at what tier. For your exact copay, pick "Medicare" above and check your plan's Summary of Benefits, or log in to Medicare.gov.

How long does a Patient Assistance Program take?

Most PAPs take 2-6 weeks from application to first fill. Ask the manufacturer about a "bridge supply" — many will ship 30 days free while your application is being reviewed so you don't go without the drug.

What if I have a high-deductible plan?

For generics, Cost Plus Drugs cash price is often cheaper than your deductible-phase copay. For brand names, the manufacturer copay card almost always wins. A GoodRx coupon can be a last resort for uncovered drugs, but it doesn't count toward your deductible.

Are there charity grants for Chronic Hepatitis C?

Charities like HealthWell Foundation, PAN Foundation, Good Days, and the National Organization for Rare Disorders provide copay help for specific conditions. Funds often run out mid-year — apply early. We list the specific grants for your condition in the options above.

More about Sofosbuvir and Velpatasvir